Early stage IT and Healthcare Investing

NeuroPace

portfoliocompanies

company snapshot

NeuroPace

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world. NeuroPace is located in Mountain View, California.

website
www.neuropace.com
Leadership
Follow The Company
Investment Team
Frank Fischer, CEO
Facebook Google+ Twitter Email LinkedIn Share